Patient characteristics at baseline. Values are mean (SD) unless otherwise specified.
| Characteristics | ITT Population, n = 193 |
|---|---|
| Sex, n (%) | |
| Male | 13 (6.7) |
| Female | 180 (93.3) |
| Age, yrs | 50.1 (10.0) |
| Race, n (%) | |
| White | 181 (93.8) |
| Black | 9 (4.7) |
| Other | 3 (1.6) |
| Weight, kg | 83.2 (21.2) |
| Height, cm | 163.8 (7.4) |
| Time since FM diagnosis, yrs, mean (range) | 6.1 (0.0–32.7) |
| No. tender points | 15.4 (2.2) |
| Time since depression diagnosis, yrs, mean (range) | 12.3 (0.3–45.8) |
| Depression diagnosis, n (%) | |
| MDD | 84 (43.5) |
| Dysthymia | 8 (4.2) |
| Depression NOS | 101 (52.3) |
| Antidepressant medication, n (%) | |
| SSRI | 101 (52.3) |
| SNRI | 92 (47.7) |
| Mean pain score | 6.7 (1.2) |
| FIQ total score | 63.3 (12.0) |
| HADS-A score | 8.3 (3.9) |
| HADS-D score | 8.0 (3.6) |
ITT: intent-to-treat; FM: fibromyalgia; MDD: major depressive disorder; NOS: not otherwise specified; SSRI: selective serotonin reuptake inhibitor; SNRI: serotonin/norepinephrine reuptake inhibitor; FIQ: Fibromyalgia Impact Questionnaire; HADS-A: Hospital Anxiety and Depression Scale-Anxiety; HADS-D: Hospital Anxiety and Depression Scale-Depression.